Understanding how to Effectively Monitor AAV Safety in Gene Therapies Employing a Local Route of Administration

Time: 12:00 pm
day: Day Two


• Exploring the differences in how inflammation is tracked locally (eye/ear) compared to systemic ROA

• Delving into the key safety indicators in local delivery of AAV gene therapy

• Reviewing the accuracy of preclinical safety monitoring in locally delivered gene therapies

• Looking to the future of how AAV safety could be tracked for local ROA during the clinical development